<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3810496</article-id><article-id pub-id-type="doi">10.1155/2013/203614</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A Drug-Target Network-Based Approach to Evaluate the Efficacy of Medicinal Plants for Type II Diabetes Mellitus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Jiangyong</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Lirong</given-names></name><xref ref-type="aff" rid="I1"/><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Gu</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Xiaojie</given-names></name><xref ref-type="aff" rid="I1"/><xref ref-type="corresp" rid="cor2">*</xref></contrib></contrib-group><aff id="I1">Beijing National Laboratory for Molecular Sciences, State Key Lab of Rare Earth Material Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China</aff><author-notes><corresp id="cor1">*Lirong Chen: <email>lirongc@pku.edu.cn</email> and </corresp><corresp id="cor2">*Xiaojie Xu: <email>xiaojxu@pku.edu.cn</email></corresp><fn fn-type="other"><p>Academic Editor: Francis B. Lewu</p></fn></author-notes><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>10</day><month>10</month><year>2013</year></pub-date><volume>2013</volume><elocation-id>203614</elocation-id><history><date date-type="received"><day>25</day><month>6</month><year>2013</year></date><date date-type="accepted"><day>19</day><month>9</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Jiangyong Gu et al.</copyright-statement><copyright-year>2013</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The use of plants as natural medicines in the treatment of type II diabetes mellitus (T2DM) has long been of special interest. In this work, we developed a docking score-weighted prediction model based on drug-target network to evaluate the efficacy of medicinal plants for T2DM. High throughput virtual screening from chemical library of natural products was adopted to calculate the binding affinity between natural products contained in medicinal plants and 33 T2DM-related proteins. The drug-target network was constructed according to the strength of the binding affinity if the molecular docking score satisfied the threshold. By linking the medicinal plant with T2DM through drug-target network, the model can predict the efficacy of natural products and medicinal plant for T2DM. Eighteen thousand nine hundred ninety-nine natural products and 1669 medicinal plants were predicted to be potentially bioactive.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Type II Diabetes mellitus (T2DM) has been a major global health problem and affects a large population worldwide [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. T2DM is a multifactorial and genetically heterogeneous disease caused by various risk factors such as insulin resistance, <italic>&#x003b2;</italic>-cell dysfunction, and obesity [<xref rid="B2" ref-type="bibr">2</xref>&#x02013;<xref rid="B5" ref-type="bibr">5</xref>]. Moreover, T2DM may cause acute cardiovascular disease, retinopathy, nephropathy, neuropathy, and kidney-related complications [<xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>]. Therefore, it demands effective drugs with minimal toxicity. The herbal medicines have been used for T2DM for thousands of years and accumulated a great deal of clinical experience. A herbal formula comprises several medicinal plants or animals and thus can affect the biological system through interactions between compounds and cellular targets [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B8" ref-type="bibr">8</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>]. The main mechanisms of herbal medicines in treating T2DM are that it increases insulin secretion and the sensitivity of insulin, inhibits glucose absorption, and reduces radicals caused by lipid peroxidation [<xref rid="B8" ref-type="bibr">8</xref>]. However, the major problem of herbal medicines is lack of scientific and clinical data to evaluate their efficacy and safety.</p><p>Network pharmacology proposed by Hopkins is a holistic approach to understand the function and behavior of a biological system at systems level in the context of biological networks and would be the next paradigm for drug discovery [<xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>]. Several efforts have been made to explore the mechanism of herbal medicines such as prediction of the active ingredients and potential targets [<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B26" ref-type="bibr">26</xref>] and screening synergistic drug combinations [<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>]. The drug-target network (DTN) which connects drugs and their target proteins is an important biological network and provides an overview of polypharmacology of drugs [<xref rid="B29" ref-type="bibr">29</xref>&#x02013;<xref rid="B32" ref-type="bibr">32</xref>]. Since medicinal plants have multiple compounds and a compound would have several target proteins, the DTN may bridge the gap between medicinal plants and diseases. In this work, we developed a computational approach based on DTN to evaluate the efficacy of medicinal plants.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Data Collection and Molecular Docking</title><p>The pathogenesis of T2DM is concerned with various proteins. We retrieved the information of these proteins from KEGG Pathway database [<xref rid="B33" ref-type="bibr">33</xref>] and DrugBank [<xref rid="B34" ref-type="bibr">34</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The pathway of T2DM was downloaded from the KEGG website (<ext-link ext-link-type="uri" xlink:href="http://www.genome.jp/dbget-bin/www_bget?hsa04930">http://www.genome.jp/dbget-bin/www_bget?hsa04930</ext-link>), and the information of T2DM-related proteins was collected. In DrugBank, we first retrieved the FDA-approved drugs for T2DM and then found the target proteins for each drug. Then we searched the ligand-protein complex structure (x-ray or NMR) for each protein from RCSB protein data bank (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/home/home.do">http://www.rcsb.org/pdb/home/home.do</ext-link>). Finally, thirty-three proteins and their information were listed in <xref ref-type="table" rid="tab1">Table 1</xref>.</p><p>The 3D structures of natural products contained in medicinal plants were retrieved from the Universal Natural Product Database (UNPD) which comprised more than 208 thousands of natural products [<xref rid="B35" ref-type="bibr">54</xref>, <xref rid="B36" ref-type="bibr">55</xref>]. The AutoDock 4.0 [<xref rid="B37" ref-type="bibr">56</xref>, <xref rid="B38" ref-type="bibr">57</xref>] was adopted to perform the virtual screening, and binding free energy-based docking score (<italic>pK</italic>
<sub><italic>i</italic></sub>) was used to evaluate the affinity between each compound and each protein. For each protein, the hetero atoms of the ligand-protein complex structure were deleted and the polar hydrogen atoms were added. The binding site of each protein was defined as a 40&#x02009;&#x02009;&#x000d7;&#x02009;&#x02009;40&#x02009;&#x02009;&#x000d7;&#x02009;&#x02009;40&#x02009;&#x000c5; cube around the original ligand with a spacing of 0.375&#x02009;&#x000c5; between the grid points. The center of binding site was located in the center of the original ligand. The molecular docking was conducted according to the protocol described previously [<xref rid="B39" ref-type="bibr">58</xref>].</p></sec><sec id="sec2.2"><title>2.2. Drug-Target Network Construction and Analysis</title><p>The drug-target network was constructed by linking the compound with target protein if the docking score satisfied the thresholds that were used to determine whether the interaction between compound and protein was strong. According to our previous study, the thresholds were set as follow: the docking score should be greater than 7.00 and the score of original ligand of corresponding protein and the top percentage of rank of docking score should be less than 10% [<xref rid="B35" ref-type="bibr">54</xref>]. The edge value was the docking score of corresponding compound and protein. Finally, the DTN consisted of 32 target proteins, 18999 compounds (the UNPD ID, chemical name, formula, molecular weight, and CAS registry number of each compound were listed in Table S1, see Table S1 in Supplementary Material available online at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2013/203614">http://dx.doi.org/10.1155/2013/203614</ext-link>), and 35076 edges (Supplementary Table S2). The glucocorticoid receptor (P04150) did not have any compounds. The compounds were derived from 1669 medicinal plants distinguished by Latin names. The DTN of potentially active compounds and proteins related with T2DM was used as a bridge to build the relationship between compound or medicinal plant and T2DM.</p></sec><sec id="sec2.3"><title>2.3. Chemical Space Analysis</title><p>The analysis of the distribution of compounds in the chemical space was conducted by principal component analysis (PCA) module in Discovery Studio. The PCA model was built with 8 descriptors: <italic>A</italic>&#x02009;&#x02009;log&#x02061;&#x02009;&#x02009;<italic>P</italic>, molecular weight, number of hydrogen-bond donors, number of hydrogen-bond acceptors, number of rotatable bonds, number of rings, number of aromatic rings, and molecular fractional polar surface area. The variances of PC1, PC2, and PC3 for compounds in <xref ref-type="fig" rid="fig2">Figure 2</xref> were 0.488, 0.186, and 0.145, respectively. The PCA of 25 FDA-approved small-molecule drugs retrieved from DrugBank was performed in the same process as above.</p></sec><sec id="sec2.4"><title>2.4. Prediction Model</title><p>Natural products are multitarget agents. The average number of target proteins was 1.84 in the DTN. Therefore, we proposed that the prediction efficacy (PE) of a compound for T2DM was the sum of its all edge values (docking scores) in the DTN:
<disp-formula id="EEq1"><label>(1)</label><mml:math id="M1"><mml:mtable><mml:mtr><mml:mtd><mml:mtext>P</mml:mtext><mml:msub><mml:mrow><mml:mtext>E</mml:mtext></mml:mrow><mml:mrow><mml:mtext>compound</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mstyle displaystyle="true"><mml:mo stretchy="false">&#x02211;</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>&#x02208;</mml:mo><mml:mi>P</mml:mi></mml:mrow><mml:mrow/></mml:munderover><mml:mrow><mml:mtext>scor</mml:mtext><mml:msub><mml:mrow><mml:mtext>e</mml:mtext></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
where <italic>P</italic> was the set of proteins related to T2DM and score<sub><italic>j</italic></sub> was the docking score between this compound and <italic>j</italic>th protein. The PE<sub>compound</sub> for each compound was listed in Table S3.</p><p>Similarly, the prediction efficacy of a medicinal plant was defined as the sum of PE of compounds contained in this plant:
<disp-formula id="EEq2"><label>(2)</label><mml:math id="M2"><mml:mtable><mml:mtr><mml:mtd><mml:mtext>P</mml:mtext><mml:msub><mml:mrow><mml:mtext>E</mml:mtext></mml:mrow><mml:mrow><mml:mtext>plant</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mstyle displaystyle="true"><mml:mo stretchy="false">&#x02211;</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mtext>P</mml:mtext><mml:msub><mml:mrow><mml:mtext>E</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mtext>compound</mml:mtext></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
where <italic>N</italic> denoted the number of compounds contained in the medicinal plant. The PE<sub>plant</sub> for each medicinal plant was listed in Table S4.</p></sec></sec><sec id="sec3"><title>3. Results and Discussion</title><sec id="sec3.1"><title>3.1. Drug-Likeness of Medicinal Natural Products for T2DM</title><p>The natural products contained in medicinal plants for T2DM had good drug-like properties. Lipinski CA and colleagues proposed the &#x0201c;rule of five&#x0201d; (molecular weight (MW) less than 500&#x02009;Da, the number of hydrogen bond acceptors (HBA) less than 10, the number of hydrogen bond donors (HBD) less than 5, and octanol-water partition coefficient (<italic>A</italic>&#x02009;&#x02009;log&#x02061;&#x02009;&#x02009;<italic>P</italic>) less than five) [<xref rid="B40" ref-type="bibr">59</xref>, <xref rid="B41" ref-type="bibr">60</xref>] to estimate solubility and permeability of compounds in drug discovery. That is, a compound was unlikely to be a drug if it disobeyed the rules. The mean and median of MW, HBA, HBD, and <italic>A</italic>&#x02009;&#x02009;log&#x02061;&#x02009;&#x02009;<italic>P</italic> of these compounds were 540.43, 494.62; 6.3, 5; 2.5, 2; and 4.94, 5.07; respectively. It indicated that most compounds would be drug-like. The wide distribution of natural products in chemical space (<xref ref-type="fig" rid="fig2">Figure 2</xref>) showed that there would be vast property (structural and functional) diversity. Moreover, the large overlap between natural products and 25&#x02009;FDA-approved small-molecule drugs for T2DM demonstrated that natural products contained in these medicinal plants had a hopeful prospect for drug discovery for T2DM.</p></sec><sec id="sec3.2"><title>3.2. Prediction Efficacy of Natural Product and Medicinal Plant</title><p>Herb medicines could simultaneously target multiple physiological processes through interactions between multiple compounds and cellular target proteins. For example, there were 105 distinct compounds contained in <italic>Hypericum perforatum</italic>, and 21 compounds existed in DTN. The herbal medicines could influence the biological system through interactions between multi-component and multi-target and thus reverse the biological networks from disease state to health state. Since a group of compounds contained in the herbal medicine could play a therapeutic role, the dosage could be reduced to reduce toxicity and side effects. For example, UNPD43323 (ormojine), UNPD194973 (ormosinin), and UNPD194973 (strychnohexamine) were the top three potential compounds (Supplementary Table S3). ormojine, ormosinin, and strychnohexamine had 27, 24, and 23 targets, respectively. The polypharmacology of natural products was very common.</p><p>The predicted efficacy of the top twenty medicinal plants for T2DM was listed in <xref ref-type="table" rid="tab2">Table 2</xref>. There were five plants (<italic>Hypericum perforatum, Ganoderma lucidum, Holarrhena antidysenterica, Celastrus orbiculatus, </italic>and<italic> Murraya euchrestifolia</italic>) where prediction efficacy was higher than 1000. We searched the literatures which reported the anti-T2DM bioactivities of the top twenty medicinal plants (<xref ref-type="table" rid="tab2">Table 2</xref>) and found that 15 medicinal plants had information of definite effectiveness against T2DM. For example, Arokiyaraj and colleagues evaluated the antihyperglycemic activity of <italic>Hypericum perforatum</italic> in diabetic rats, and it produced significant reduction in plasma glucose level [<xref rid="B42" ref-type="bibr">35</xref>].</p></sec><sec id="sec3.3"><title>3.3. Clinical Herbal Formula</title><p>Tangminling which was a widely used herbal formula in China to treat T2DM comprised eleven medicinal herbs (<italic>Trichosanthes kirilowii</italic>, <italic>Citrus sinensis</italic>, <italic>Bupleurum chinense</italic>, <italic>Rheum officinale</italic>, <italic>Astragalus membranaceus</italic>, <italic>Pinellia ternata</italic>, <italic>Scutellaria discolor</italic>, <italic>Crataegus pinnatifida var</italic>. <italic>major</italic>, <italic>Paeonia albiflora</italic>, <italic>Prunus mume</italic>, and <italic>Picrorhiza kurroa</italic>) [<xref rid="B3" ref-type="bibr">3</xref>]. The prediction efficacy of each medicinal plant was 493.04, 199.26, 36.06, 29.08, 15.12, 14.80, 7.83, 7.09, 7.07, 7.06, and 7.04, respectively. It indicated that all plants could play a role in the treatment of T2DM. However, the prediction efficacy of eleven herbs differed considerably from each other. It meant that <italic>Trichosanthes kirilowii</italic> and <italic>Citrus sinensis</italic> played major roles (sovereign herbs). Meanwhile, The others worked as assistants which may strengthen the efficacy of sovereign herbs or reduce the toxicity.</p></sec></sec><sec id="sec4"><title>4. Conclusions</title><p>Medicinal plants are potentially important for novel therapeutic drugs. It is currently estimated that approximately 420,000 plant species exist in nature [<xref rid="B61" ref-type="bibr">61</xref>]. However, only 10,000 of all plants have documented medicinal use [<xref rid="B62" ref-type="bibr">62</xref>]. Therefore, there are potentially many more important pharmaceutical applications of plants to be exploited. Traditional method (from selecting plants to separating compounds following bioassay) is time-consuming. In this work, we developed a molecular docking score-weighted prediction model based on drug-target network to evaluate the efficacy of natural products and medicinal plants for T2DM. Natural products contained in the medicinal plants would target several cellular target proteins. The prediction efficacy of this model took into account all potential interactions between multicomponents and targets. Therefore, the prediction efficacy was an overall evaluation at systems level. Fifteen out of the top twenty medicinal plants had reported bioactivity against T2DM in literatures. This approach may promote the research on the use of medicinal plants to treat T2DM and drug discovery from natural products.</p></sec><sec sec-type="supplementary-material" id="supplementary-material-sec"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="f1"><caption><p>The supplementary materials comprise four tables of large datasets. Table S1 listed the identification information of 18999 natural products. Table S2 listed the natural products-target proteins interaction network (DTN). Table S3 and Table S4 listed the prediction efficacy of natural products and medicinal plants for T2DM, respectively.</p></caption><media xlink:href="203614.f1.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><title>Conflict of Interests</title><p>The authors declare that they have no conflict of interests.</p></ack><ack><title>Acknowledgments</title><p>This work was financially supported by the National Key Special Project of Science and Technology for Innovation Drugs (Grant nos. 2012ZX09501001-004 and 2013ZX09402202). The calculations were performed on TianHe-1(A) at the National Supercomputer Center in Tianjin.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name></person-group><article-title>Current views on type 2 diabetes</article-title><source><italic>Journal of Endocrinology</italic></source><year>2010</year><volume>204</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="other">2-s2.0-73949146152</pub-id><pub-id pub-id-type="pmid">19770178</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Goldstein</surname><given-names>BJ</given-names></name><name><surname>van Haeften</surname><given-names>TW</given-names></name></person-group><article-title>Type 2 diabetes: principles of pathogenesis and therapy</article-title><source><italic>The Lancet</italic></source><year>2005</year><volume>365</volume><issue>9467</issue><fpage>1333</fpage><lpage>1346</lpage><pub-id pub-id-type="other">2-s2.0-17044386953</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus</article-title><source><italic>Computational Biology and Chemistry</italic></source><year>2011</year><volume>35</volume><issue>5</issue><fpage>293</fpage><lpage>297</lpage><pub-id pub-id-type="other">2-s2.0-80052088034</pub-id><pub-id pub-id-type="pmid">22000800</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname><given-names>U</given-names></name><name><surname>Ukil</surname><given-names>S</given-names></name><name><surname>Dimitrova</surname><given-names>N</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name></person-group><article-title>Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications</article-title><source><italic>PLoS ONE</italic></source><year>2009</year><volume>4</volume><issue>12</issue><pub-id pub-id-type="other">2-s2.0-77949508610</pub-id><pub-id pub-id-type="publisher-id">e8100</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SC</given-names><suffix>Jr.</suffix></name></person-group><article-title>Multiple risk factors for cardiovascular disease and diabetes mellitus</article-title><source><italic>The American Journal of Medicine</italic></source><year>2007</year><volume>120</volume><issue>3</issue><fpage>S3</fpage><lpage>S11</lpage><pub-id pub-id-type="other">2-s2.0-33847063390</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzone</surname><given-names>T</given-names></name><name><surname>Chait</surname><given-names>A</given-names></name><name><surname>Plutzky</surname><given-names>J</given-names></name></person-group><article-title>Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies</article-title><source><italic>The Lancet</italic></source><year>2008</year><volume>371</volume><issue>9626</issue><fpage>1800</fpage><lpage>1809</lpage><pub-id pub-id-type="other">2-s2.0-43849095463</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><etal/></person-group><article-title>Modeling compound-target interaction network of traditional chinese medicines for type II diabetes mellitus: insight for polypharmacology and drug design</article-title><source><italic>Journal of Chemical Information and Modeling</italic></source><year>2013</year><volume>53</volume><issue>7</issue><fpage>1787</fpage><lpage>1803</lpage><pub-id pub-id-type="pmid">23768230</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>TT</given-names></name><name><surname>Jiang</surname><given-names>JG</given-names></name></person-group><article-title>Active ingredients of traditional chinese medicine in the treatment of diabetes and diabetic complications</article-title><source><italic>Expert Opinion on Investigational Drugs</italic></source><year>2012</year><volume>21</volume><issue>11</issue><fpage>1625</fpage><lpage>1642</lpage><pub-id pub-id-type="pmid">22862558</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H-L</given-names></name><name><surname>Tong</surname><given-names>PCY</given-names></name><name><surname>Chan</surname><given-names>JCN</given-names></name></person-group><article-title>Traditional Chinese medicine in the treatment of diabetes</article-title><source><italic>Nutritional Management of Diabetes Mellitus and Dysmetabolic Syndrome</italic></source><year>2006</year><volume>11</volume><fpage>15</fpage><lpage>29</lpage><pub-id pub-id-type="other">2-s2.0-33750111898</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Traditional chinese medicine-based network pharmacology could lead to new multicompound drug discovery</article-title><source><italic>Evidence-Based Complementary and Alternative Medicine</italic></source><year>2012</year><volume>2012</volume><fpage>11 pages</fpage><pub-id pub-id-type="publisher-id">149762</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name></person-group><article-title>Network target for screening synergistic drug combinations with application to traditional Chinese medicine</article-title><source><italic>BMC Systems Biology</italic></source><year>2011</year><issue> 1</issue><issue>1, article S10</issue><pub-id pub-id-type="other">2-s2.0-79959199033</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>T</given-names></name><name><surname>Tan</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network</article-title><source><italic>Molecular BioSystems</italic></source><year>2010</year><volume>6</volume><issue>4</issue><fpage>613</fpage><lpage>619</lpage><pub-id pub-id-type="other">2-s2.0-77949682260</pub-id><pub-id pub-id-type="pmid">20237638</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>Network systems underlying traditional Chinese medicine syndrome and herb formula</article-title><source><italic>Current Bioinformatics</italic></source><year>2009</year><volume>4</volume><issue>3</issue><fpage>188</fpage><lpage>196</lpage><pub-id pub-id-type="other">2-s2.0-70549112019</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>MQ</given-names></name><name><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>Network-based global inference of human disease genes</article-title><source><italic>Molecular Systems Biology</italic></source><year>2008</year><volume>4, article 189</volume><pub-id pub-id-type="other">2-s2.0-43249114206</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name><name><surname>Wang</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Drug-likeness analysis of traditional chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds, non-drug-like compounds, and natural compounds from traditional chinese medicines</article-title><source><italic>Journal of Cheminformatics</italic></source><year>2013</year><volume>5</volume><issue>1</issue></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>MY</given-names></name><name><surname>Tian</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name><etal/></person-group><article-title>Drug-likeness analysis of traditional chinese medicines: 1. Property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional chinese medicines</article-title><source><italic>Journal of Cheminformatics</italic></source><year>2012</year><volume>4</volume><issue>1, article 31</issue></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>JM</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name><etal/></person-group><article-title>Drug-likeness analysis of traditional chinese medicines: 3. Prediction of drug-likeness using machine learning approaches</article-title><source><italic>Molecular Pharmaceutics</italic></source><year>2012</year><volume>9</volume><issue>10</issue><fpage>2875</fpage><lpage>2886</lpage><pub-id pub-id-type="pmid">22738405</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>AL</given-names></name></person-group><article-title>Network pharmacology</article-title><source><italic>Nature Biotechnology</italic></source><year>2007</year><volume>25</volume><issue>10</issue><fpage>1110</fpage><lpage>1111</lpage><pub-id pub-id-type="other">2-s2.0-35148824614</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>AL</given-names></name></person-group><article-title>Network pharmacology: the next paradigm in drug discovery</article-title><source><italic>Nature Chemical Biology</italic></source><year>2008</year><volume>4</volume><issue>11</issue><fpage>682</fpage><lpage>690</lpage><pub-id pub-id-type="other">2-s2.0-54249155522</pub-id><pub-id pub-id-type="pmid">18936753</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name></person-group><article-title>Traditional chinese medicine network pharmacology: theory, methodology and application</article-title><source><italic>Chinese Journal of Natural Medicines</italic></source><year>2013</year><volume>11</volume><issue>2</issue><fpage>110</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">23787177</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>WY</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Network pharmacology-based prediction of the active ingredients and potential targets of chinese herbal radix curcumae formula for application to cardiovascular disease</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2013</year><volume>145</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">23142198</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>Network-based relating pharmacological and genomic spaces for drug target identification</article-title><source><italic>PLoS ONE</italic></source><year>2010</year><volume>5</volume><issue>7</issue><pub-id pub-id-type="other">2-s2.0-77955628292</pub-id><pub-id pub-id-type="publisher-id">e11764</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Identification of responsive gene modules by network-based gene clustering and extending: application to inflammation and angiogenesis</article-title><source><italic>BMC Systems Biology</italic></source><year>2010</year><volume>4, article 47</volume><pub-id pub-id-type="other">2-s2.0-77951076168</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>LX</given-names></name><name><surname>Bao</surname><given-names>YW</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Material basis of chinese herbal formulas explored by combining pharmacokinetics with network pharmacology</article-title><source><italic>Plos ONE</italic></source><year>2013</year><volume>8</volume><issue>2</issue></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Predicting new molecular targets for rhein using network pharmacology</article-title><source><italic>BMC Systems Biology</italic></source><year>2012</year><volume>6, article 20</volume><pub-id pub-id-type="other">2-s2.0-84858605520</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>Molecular networks for the study of TCM pharmacology</article-title><source><italic>Briefings in Bioinformatics</italic></source><year>2009</year><volume>11</volume><issue>4</issue><fpage>417</fpage><lpage>430</lpage><pub-id pub-id-type="other">2-s2.0-77955039434</pub-id><pub-id pub-id-type="pmid">20038567</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name></person-group><article-title>A formal model for analyzing drug combination effects and its application in TNF-<italic>&#x003b1;</italic>-induced NF<italic>&#x003ba;</italic>B pathway</article-title><source><italic>BMC Systems Biology</italic></source><year>2010</year><volume>4, article 50</volume><pub-id pub-id-type="other">2-s2.0-77951134093</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name></person-group><article-title>Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae</article-title><source><italic>BMC Bioinformatics</italic></source><year>2010</year><volume>11</volume><issue>11, article S6</issue><pub-id pub-id-type="other">2-s2.0-78650832745</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yildirim</surname><given-names>MA</given-names></name><name><surname>Goh</surname><given-names>K-I</given-names></name><name><surname>Cusick</surname><given-names>ME</given-names></name><name><surname>Barab&#x000e1;si</surname><given-names>A-L</given-names></name><name><surname>Vidal</surname><given-names>M</given-names></name></person-group><article-title>Drug-target network</article-title><source><italic>Nature Biotechnology</italic></source><year>2007</year><volume>25</volume><issue>10</issue><fpage>1119</fpage><lpage>1126</lpage><pub-id pub-id-type="other">2-s2.0-35148838537</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janga</surname><given-names>SC</given-names></name><name><surname>Tzakos</surname><given-names>A</given-names></name></person-group><article-title>Structure and organization of drug-target networks: insights from genomic approaches for drug discovery</article-title><source><italic>Molecular BioSystems</italic></source><year>2009</year><volume>5</volume><issue>12</issue><fpage>1536</fpage><lpage>1548</lpage><pub-id pub-id-type="other">2-s2.0-72949101438</pub-id><pub-id pub-id-type="pmid">19763339</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mestres</surname><given-names>J</given-names></name><name><surname>Gregori-Puigjan&#x000e9;</surname><given-names>E</given-names></name><name><surname>Valverde</surname><given-names>S</given-names></name><name><surname>Sol&#x000e9;</surname><given-names>RV</given-names></name></person-group><article-title>The topology of drug-target interaction networks: implicit dependence on drug properties and target families</article-title><source><italic>Molecular BioSystems</italic></source><year>2009</year><volume>5</volume><issue>9</issue><fpage>1051</fpage><lpage>1057</lpage><pub-id pub-id-type="other">2-s2.0-68949119585</pub-id><pub-id pub-id-type="pmid">19668871</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>I</given-names></name><name><surname>Mestres</surname><given-names>J</given-names></name></person-group><article-title>Drug-target networks</article-title><source><italic>Molecular Informatics</italic></source><year>2010</year><volume>29</volume><issue>1-2</issue><fpage>10</fpage><lpage>14</lpage><pub-id pub-id-type="other">2-s2.0-77952627289</pub-id><pub-id pub-id-type="pmid">27463845</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Kegg for integration and interpretation of large-scale molecular data sets</article-title><source><italic>Nucleic Acids Research</italic></source><year>2012</year><volume>40</volume><issue>1</issue><fpage>D109</fpage><lpage>D114</lpage><pub-id pub-id-type="pmid">22080510</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knox</surname><given-names>C</given-names></name><name><surname>Law</surname><given-names>V</given-names></name><name><surname>Jewison</surname><given-names>T</given-names></name><etal/></person-group><article-title>DrugBank 3.0: a comprehensive resource for &#x0201c;Omics&#x0201d; research on drugs</article-title><source><italic>Nucleic Acids Research</italic></source><year>2011</year><volume>39</volume><issue>1</issue><fpage>D1035</fpage><lpage>D1041</lpage><pub-id pub-id-type="other">2-s2.0-78651287426</pub-id><pub-id pub-id-type="pmid">21059682</pub-id></element-citation></ref><ref id="B42"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arokiyaraj</surname><given-names>S</given-names></name><name><surname>Balamurugan</surname><given-names>R</given-names></name><name><surname>Augustian</surname><given-names>P</given-names></name></person-group><article-title>Antihyperglycemic effect of Hypericum perforatum ethyl acetate extract on streptozotocin-induced diabetic rats</article-title><source><italic>Asian Pacific Journal of Tropical Biomedicine</italic></source><year>2011</year><volume>1</volume><issue>5</issue><fpage>386</fpage><lpage>390</lpage><pub-id pub-id-type="other">2-s2.0-79959471205</pub-id><pub-id pub-id-type="pmid">23569798</pub-id></element-citation></ref><ref id="B43"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasanein</surname><given-names>P</given-names></name><name><surname>Shahidi</surname><given-names>S</given-names></name></person-group><article-title>Effects of Hypericum perforatum extract on diabetes-induced learning and memory impairment in rats</article-title><source><italic>Phytotherapy Research</italic></source><year>2011</year><volume>25</volume><issue>4</issue><fpage>544</fpage><lpage>549</lpage><pub-id pub-id-type="other">2-s2.0-79953223746</pub-id><pub-id pub-id-type="pmid">20836158</pub-id></element-citation></ref><ref id="B44"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>Y-H</given-names></name><name><surname>Lin</surname><given-names>Z-B</given-names></name></person-group><article-title>Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species</article-title><source><italic>Acta Pharmacologica Sinica</italic></source><year>2002</year><volume>23</volume><issue>9</issue><fpage>787</fpage><lpage>791</lpage><pub-id pub-id-type="other">2-s2.0-0036712254</pub-id><pub-id pub-id-type="pmid">12230945</pub-id></element-citation></ref><ref id="B45"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>KM</given-names></name><name><surname>Chatterjee</surname><given-names>K</given-names></name><name><surname>De</surname><given-names>D</given-names></name><etal/></person-group><article-title>Efficacy of aqueous extract of seed of holarrhena antidysenterica for the management of diabetes in experimental model rat: a correlative study with antihyperlipidemic activity</article-title><source><italic>International Journal of Applied Research in Natural Products</italic></source><year>2009</year><volume>2</volume><issue>3</issue><fpage>13</fpage><lpage>21</lpage></element-citation></ref><ref id="B46"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mana</surname><given-names>S</given-names></name><name><surname>Singhal</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name></person-group><article-title>Hypoglycemic effect of Holarrhena antidysenterica seeds on streptozotocin induced diabetic rats</article-title><source><italic>International Journal of PharmTech Research</italic></source><year>2010</year><volume>2</volume><issue>2</issue><fpage>1325</fpage><lpage>1329</lpage><pub-id pub-id-type="other">2-s2.0-77954729861</pub-id></element-citation></ref><ref id="B47"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samudram</surname><given-names>P</given-names></name><name><surname>Vasuki</surname><given-names>R</given-names></name><name><surname>Rajeshwari</surname><given-names>H</given-names></name><name><surname>Geetha</surname><given-names>A</given-names></name><name><surname>Sathiya Moorthi</surname><given-names>P</given-names></name></person-group><article-title>Antioxidant and antihepatotoxic activities of ethanolic crude extract of Melia azedarach and Piper longum</article-title><source><italic>Journal of Medicinal Plant Research</italic></source><year>2009</year><volume>3</volume><issue>12</issue><fpage>1078</fpage><lpage>1083</lpage><pub-id pub-id-type="other">2-s2.0-75649102128</pub-id></element-citation></ref><ref id="B48"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna Murthy</surname><given-names>B</given-names></name><name><surname>Nammi</surname><given-names>S</given-names></name><name><surname>Kota</surname><given-names>MK</given-names></name><name><surname>Krishna Rao</surname><given-names>RV</given-names></name><name><surname>Koteswara Rao</surname><given-names>N</given-names></name><name><surname>Annapurna</surname><given-names>A</given-names></name></person-group><article-title>Evaluation of hypoglycemic and antihyperglycemic effects of Datura metel (Linn.) seeds in normal and alloxan-induced diabetic rats</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2004</year><volume>91</volume><issue>1</issue><fpage>95</fpage><lpage>98</lpage><pub-id pub-id-type="other">2-s2.0-1442351150</pub-id><pub-id pub-id-type="pmid">15036475</pub-id></element-citation></ref><ref id="B49"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murch</surname><given-names>SJ</given-names></name><name><surname>Alan</surname><given-names>AR</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Saxena</surname><given-names>PK</given-names></name></person-group><article-title>Melatonin and serotonin in flowers and fruits of Datura metel L</article-title><source><italic>Journal of Pineal Research</italic></source><year>2009</year><volume>47</volume><issue>3</issue><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="other">2-s2.0-69949140809</pub-id><pub-id pub-id-type="pmid">19732299</pub-id></element-citation></ref><ref id="B50"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asok Kumar</surname><given-names>K</given-names></name><name><surname>Uma Maheswari</surname><given-names>M</given-names></name><name><surname>Sivashanmugam</surname><given-names>AT</given-names></name><name><surname>Subhadra Devi</surname><given-names>V</given-names></name><name><surname>Prasanth</surname><given-names>NV</given-names></name><name><surname>Ravi</surname><given-names>TK</given-names></name></person-group><article-title>Hypoglycemic effect of Ficus microcarpa leaves (Chinese Banyan) on alloxan-induced diabetic rats</article-title><source><italic>Journal of Biological Sciences</italic></source><year>2007</year><volume>7</volume><issue>2</issue><fpage>321</fpage><lpage>326</lpage><pub-id pub-id-type="other">2-s2.0-34250884535</pub-id></element-citation></ref><ref id="B51"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Treatment of diabetic nephropathy with tripterygium wilfordii hook f extract: a prospective, randomized, controlled clinical trial</article-title><source><italic>Journal of Translational Medicine</italic></source><year>2013</year><volume>11, article 134</volume></element-citation></ref><ref id="B52"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborthy</surname><given-names>GS</given-names></name><name><surname>Arora</surname><given-names>R</given-names></name><name><surname>Majee</surname><given-names>C</given-names></name></person-group><article-title>Antidiabetic and antihyperlipidaemic effect of hydro-alcoholic extract of calendula officinalis</article-title><source><italic>International Research Journal of Pharmacy</italic></source><year>2011</year><volume>2</volume><issue>1</issue><fpage>61</fpage><lpage>65</lpage></element-citation></ref><ref id="B53"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orhan</surname><given-names>N</given-names></name><name><surname>Aslan</surname><given-names>M</given-names></name><name><surname>Orhan</surname><given-names>DD</given-names></name><name><surname>Ergun</surname><given-names>F</given-names></name><name><surname>Ye&#x0015f;ilada</surname><given-names>E</given-names></name></person-group><article-title>In-vivo assessment of antidiabetic and antioxidant activities of grapevine leaves (Vitis vinifera) in diabetic rats</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2006</year><volume>108</volume><issue>2</issue><fpage>280</fpage><lpage>286</lpage><pub-id pub-id-type="other">2-s2.0-33750312811</pub-id><pub-id pub-id-type="pmid">16824713</pub-id></element-citation></ref><ref id="B54"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aderibigbe</surname><given-names>AO</given-names></name><name><surname>Emudianughe</surname><given-names>TS</given-names></name><name><surname>Lawal</surname><given-names>BAS</given-names></name></person-group><article-title>Evaluation of the antidiabetic action of Mangifera indica in mice</article-title><source><italic>Phytotherapy Research</italic></source><year>2001</year><volume>15</volume><issue>5</issue><fpage>456</fpage><lpage>458</lpage><pub-id pub-id-type="other">2-s2.0-0034893114</pub-id><pub-id pub-id-type="pmid">11507745</pub-id></element-citation></ref><ref id="B55"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaleem</surname><given-names>M</given-names></name><name><surname>Sheema</surname><given-names>S</given-names></name><name><surname>Sarmad</surname><given-names>H</given-names></name><name><surname>Bano</surname><given-names>B</given-names></name></person-group><article-title>Protective effects of Piper nigrum and Vinca rosea in alloxan induced diabetic rats</article-title><source><italic>Indian Journal of Physiology and Pharmacology</italic></source><year>2005</year><volume>49</volume><issue>1</issue><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="other">2-s2.0-14044274981</pub-id><pub-id pub-id-type="pmid">15881860</pub-id></element-citation></ref><ref id="B56"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asano</surname><given-names>N</given-names></name><name><surname>Nash</surname><given-names>RJ</given-names></name><name><surname>Molyneux</surname><given-names>RJ</given-names></name><name><surname>Fleet</surname><given-names>GWJ</given-names></name></person-group><article-title>Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application</article-title><source><italic>Tetrahedron Asymmetry</italic></source><year>2000</year><volume>11</volume><issue>8</issue><fpage>1645</fpage><lpage>1680</lpage><pub-id pub-id-type="other">2-s2.0-0034607947</pub-id></element-citation></ref><ref id="B57"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ooi</surname><given-names>CP</given-names></name><name><surname>Yassin</surname><given-names>Z</given-names></name><name><surname>Hamid</surname><given-names>T-A</given-names></name></person-group><article-title>Momordica charantia for type 2 diabetes mellitus</article-title><source><italic>Cochrane Database of Systematic Reviews</italic></source><year>2010</year><volume>2</volume><pub-id pub-id-type="other">2-s2.0-77950919479</pub-id></element-citation></ref><ref id="B58"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>L</given-names></name><name><surname>Birtwhistle</surname><given-names>R</given-names></name><name><surname>Kotecha</surname><given-names>J</given-names></name><name><surname>Hannah</surname><given-names>S</given-names></name><name><surname>Cuthbertson</surname><given-names>S</given-names></name></person-group><article-title>Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review</article-title><source><italic>British Journal of Nutrition</italic></source><year>2009</year><volume>102</volume><issue>12</issue><fpage>1703</fpage><lpage>1708</lpage><pub-id pub-id-type="other">2-s2.0-74949111350</pub-id><pub-id pub-id-type="pmid">19825210</pub-id></element-citation></ref><ref id="B59"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazmi</surname><given-names>I</given-names></name><name><surname>Rahman</surname><given-names>M</given-names></name><name><surname>Afzal</surname><given-names>M</given-names></name><etal/></person-group><article-title>Anti-diabetic potential of ursolic acid stearoyl glucoside: a new triterpenic gycosidic ester from Lantana camara</article-title><source><italic>Fitoterapia</italic></source><year>2012</year><volume>83</volume><issue>1</issue><fpage>142</fpage><lpage>146</lpage><pub-id pub-id-type="other">2-s2.0-83055184172</pub-id><pub-id pub-id-type="pmid">22051701</pub-id></element-citation></ref><ref id="B60"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>P</given-names></name><name><surname>Tamrakar</surname><given-names>AK</given-names></name><name><surname>Ahmad</surname><given-names>R</given-names></name><etal/></person-group><article-title>Antihyperglycaemic activity of Ceriops tagal in normoglycaemic and streptozotocin-induced diabetic rats</article-title><source><italic>Medicinal Chemistry Research</italic></source><year>2008</year><volume>17</volume><issue>2-7</issue><fpage>74</fpage><lpage>84</lpage><pub-id pub-id-type="other">2-s2.0-52949089037</pub-id></element-citation></ref><ref id="B35"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>JY</given-names></name><name><surname>Gui</surname><given-names>YS</given-names></name><name><surname>Chen</surname><given-names>LR</given-names></name><etal/></person-group><article-title>Use of natural products as chemical library for drug discovery and network pharmacology</article-title><source><italic>Plos ONE</italic></source><year>2013</year><volume>8</volume><issue>4</issue><pub-id pub-id-type="publisher-id">e62839</pub-id></element-citation></ref><ref id="B36"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>A 3D structure database of components from Chinese traditional medicinal herbs</article-title><source><italic>Journal of Chemical Information and Computer Sciences</italic></source><year>2002</year><volume>42</volume><issue>3</issue><fpage>481</fpage><lpage>489</lpage><pub-id pub-id-type="other">2-s2.0-0036557840</pub-id><pub-id pub-id-type="pmid">12086505</pub-id></element-citation></ref><ref id="B37"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Kumar</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Wallqvist</surname><given-names>A</given-names></name><name><surname>Reifman</surname><given-names>J</given-names></name></person-group><article-title>DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0</article-title><source><italic>Chemistry Central Journal</italic></source><year>2008</year><volume>2</volume><issue>1, article 18</issue><pub-id pub-id-type="other">2-s2.0-52249109585</pub-id></element-citation></ref><ref id="B38"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>GM</given-names></name><name><surname>Ruth</surname><given-names>H</given-names></name><name><surname>Lindstrom</surname><given-names>W</given-names></name><etal/></person-group><article-title>Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</article-title><source><italic>Journal of Computational Chemistry</italic></source><year>2009</year><volume>30</volume><issue>16</issue><fpage>2785</fpage><lpage>2791</lpage><pub-id pub-id-type="other">2-s2.0-70349932423</pub-id><pub-id pub-id-type="pmid">19399780</pub-id></element-citation></ref><ref id="B39"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>JY</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>LR</given-names></name><etal/></person-group><article-title>Platelet aggregation pathway network-based approach for evaluating compounds efficacy</article-title><source><italic>Evidence-Based Complementary and Alternative Medicine</italic></source><year>2013</year><volume>2013</volume><fpage>8 pages</fpage><pub-id pub-id-type="publisher-id">425707</pub-id></element-citation></ref><ref id="B40"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipinski</surname><given-names>CA</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Dominy</surname><given-names>BW</given-names></name><name><surname>Feeney</surname><given-names>PJ</given-names></name></person-group><article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title><source><italic>Advanced Drug Delivery Reviews</italic></source><year>1997</year><volume>23</volume><issue>1&#x02013;3</issue><fpage>3</fpage><lpage>25</lpage><pub-id pub-id-type="other">2-s2.0-0031024171</pub-id></element-citation></ref><ref id="B41"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipinski</surname><given-names>CA</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Dominy</surname><given-names>BW</given-names></name><name><surname>Feeney</surname><given-names>PJ</given-names></name></person-group><article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title><source><italic>Advanced Drug Delivery Reviews</italic></source><year>2001</year><volume>46</volume><issue>1&#x02013;3</issue><fpage>3</fpage><lpage>26</lpage><pub-id pub-id-type="other">2-s2.0-0035289779</pub-id><pub-id pub-id-type="pmid">11259830</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vuorela</surname><given-names>P</given-names></name><name><surname>Leinonen</surname><given-names>M</given-names></name><name><surname>Saikku</surname><given-names>P</given-names></name><etal/></person-group><article-title>Natural products in the process of finding new drug candidates</article-title><source><italic>Current Medicinal Chemistry</italic></source><year>2004</year><volume>11</volume><issue>11</issue><fpage>1375</fpage><lpage>1389</lpage><pub-id pub-id-type="other">2-s2.0-2942566175</pub-id><pub-id pub-id-type="pmid">15180572</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McChesney</surname><given-names>JD</given-names></name><name><surname>Venkataraman</surname><given-names>SK</given-names></name><name><surname>Henri</surname><given-names>JT</given-names></name></person-group><article-title>Plant natural products: back to the future or into extinction?</article-title><source><italic>Phytochemistry</italic></source><year>2007</year><volume>68</volume><issue>14</issue><fpage>2015</fpage><lpage>2022</lpage><pub-id pub-id-type="other">2-s2.0-34447096207</pub-id><pub-id pub-id-type="pmid">17574638</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The work flow of this approach.</p></caption><graphic xlink:href="ECAM2013-203614.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>The distribution in chemical space according to PCA of natural products contained in medicinal plants and 25&#x02009;FDA-approved drugs for T2DM. The black dots and green triangles represent natural products and FDA-approved drugs, respectively.</p></caption><graphic xlink:href="ECAM2013-203614.002"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>List of 33 proteins related with T2DM for molecular docking.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Index</th><th align="center" rowspan="1" colspan="1">UniProt entry</th><th align="center" rowspan="1" colspan="1">PDB entry</th><th align="left" rowspan="1" colspan="1">Protein name</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">O43451</td><td align="center" rowspan="1" colspan="1">3CTT</td><td align="left" rowspan="1" colspan="1">Maltase-glucoamylase, intestinal</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">P01308</td><td align="center" rowspan="1" colspan="1">1TYM</td><td align="left" rowspan="1" colspan="1">Insulin</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">P01375</td><td align="center" rowspan="1" colspan="1">2AZ5</td><td align="left" rowspan="1" colspan="1">Tumor necrosis factor alpha</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">P04150</td><td align="center" rowspan="1" colspan="1">3H52</td><td align="left" rowspan="1" colspan="1">Glucocorticoid receptor</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">P04746</td><td align="center" rowspan="1" colspan="1">1XDO</td><td align="left" rowspan="1" colspan="1">Pancreatic alpha-amylase</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">P05121</td><td align="center" rowspan="1" colspan="1">3UT3</td><td align="left" rowspan="1" colspan="1">Plasminogen activator inhibitor 1</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">P06213</td><td align="center" rowspan="1" colspan="1">3EKN</td><td align="left" rowspan="1" colspan="1">Insulin receptor</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">P07339</td><td align="center" rowspan="1" colspan="1">1LYW</td><td align="left" rowspan="1" colspan="1">Cathepsin D</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">P08069</td><td align="center" rowspan="1" colspan="1">3I81</td><td align="left" rowspan="1" colspan="1">Insulin-like growth factor 1 receptor</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">P11474</td><td align="center" rowspan="1" colspan="1">3K6P</td><td align="left" rowspan="1" colspan="1">Steroid hormone receptor ERR1</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">P12821</td><td align="center" rowspan="1" colspan="1">3L3N</td><td align="left" rowspan="1" colspan="1">Angiotensin-converting enzyme</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">P13569</td><td align="center" rowspan="1" colspan="1">3GD7</td><td align="left" rowspan="1" colspan="1">Cystic fibrosis transmembrane conductance regulator</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">P14410</td><td align="center" rowspan="1" colspan="1">3LPP</td><td align="left" rowspan="1" colspan="1">Sucrase-isomaltase, intestinal</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">P14618</td><td align="center" rowspan="1" colspan="1">3BJF</td><td align="left" rowspan="1" colspan="1">Pyruvate kinase isozymes M1/M2</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">P14735</td><td align="center" rowspan="1" colspan="1">3E4A</td><td align="left" rowspan="1" colspan="1">Insulin-degrading enzyme</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">P19367</td><td align="center" rowspan="1" colspan="1">1DGK</td><td align="left" rowspan="1" colspan="1">Hexokinase-1</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">P27361</td><td align="center" rowspan="1" colspan="1">2ZOQ</td><td align="left" rowspan="1" colspan="1">Mitogen-activated protein kinase 3</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">P27487</td><td align="center" rowspan="1" colspan="1">3G0D</td><td align="left" rowspan="1" colspan="1">Dipeptidyl peptidase 4</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">P27986</td><td align="center" rowspan="1" colspan="1">4A55</td><td align="left" rowspan="1" colspan="1">Phosphatidylinositol 3-kinase regulatory subunit alpha</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">P28482</td><td align="center" rowspan="1" colspan="1">3I5Z</td><td align="left" rowspan="1" colspan="1">Mitogen-activated protein kinase 1</td></tr><tr><td align="left" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">P30613</td><td align="center" rowspan="1" colspan="1">2VGF</td><td align="left" rowspan="1" colspan="1">Pyruvate kinase isozymes R/L</td></tr><tr><td align="left" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">P35557</td><td align="center" rowspan="1" colspan="1">3IMX</td><td align="left" rowspan="1" colspan="1">Glucokinase</td></tr><tr><td align="left" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">P35568</td><td align="center" rowspan="1" colspan="1">2Z8C</td><td align="left" rowspan="1" colspan="1">Insulin receptor substrate 1</td></tr><tr><td align="left" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">P37231</td><td align="center" rowspan="1" colspan="1">3H0A</td><td align="left" rowspan="1" colspan="1">Peroxisome proliferator-activated receptor gamma</td></tr><tr><td align="left" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">P42336</td><td align="center" rowspan="1" colspan="1">3HHM</td><td align="left" rowspan="1" colspan="1">Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform</td></tr><tr><td align="left" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">P42345</td><td align="center" rowspan="1" colspan="1">1FAP</td><td align="left" rowspan="1" colspan="1">Serine/threonine-protein kinase mTOR</td></tr><tr><td align="left" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">P43220</td><td align="center" rowspan="1" colspan="1">3C59</td><td align="left" rowspan="1" colspan="1">Glucagon-like peptide 1 receptor</td></tr><tr><td align="left" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">P45983</td><td align="center" rowspan="1" colspan="1">3PZE</td><td align="left" rowspan="1" colspan="1">Mitogen-activated protein kinase 8</td></tr><tr><td align="left" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">P45984</td><td align="center" rowspan="1" colspan="1">3NPC</td><td align="left" rowspan="1" colspan="1">Mitogen-activated protein kinase 9</td></tr><tr><td align="left" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">P48736</td><td align="center" rowspan="1" colspan="1">3SD5</td><td align="left" rowspan="1" colspan="1">Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform</td></tr><tr><td align="left" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">P53779</td><td align="center" rowspan="1" colspan="1">3TTI</td><td align="left" rowspan="1" colspan="1">Mitogen-activated protein kinase 10</td></tr><tr><td align="left" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">P62508</td><td align="center" rowspan="1" colspan="1">2P7A</td><td align="left" rowspan="1" colspan="1">Estrogen-related receptor gamma</td></tr><tr><td align="left" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">Q9BYF1</td><td align="center" rowspan="1" colspan="1">1R4L</td><td align="left" rowspan="1" colspan="1">Angiotensin-converting enzyme 2</td></tr></tbody></table></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Top twenty potential medicinal plants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Rank</th><th align="center" rowspan="1" colspan="1">Latin name</th><th align="center" rowspan="1" colspan="1">PE<sub>plant</sub>
</th><th align="center" rowspan="1" colspan="1">Reported bioactivity</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">
<italic>Hypericum perforatum </italic>
</td><td align="center" rowspan="1" colspan="1">1777.81</td><td align="center" rowspan="1" colspan="1">[<xref rid="B42" ref-type="bibr">35</xref>, <xref rid="B43" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">
<italic>Ganoderma lucidum </italic>
</td><td align="center" rowspan="1" colspan="1">1560.05</td><td align="center" rowspan="1" colspan="1">[<xref rid="B44" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">
<italic>Holarrhena antidysenterica </italic>
</td><td align="center" rowspan="1" colspan="1">1147.22</td><td align="center" rowspan="1" colspan="1">[<xref rid="B45" ref-type="bibr">38</xref>, <xref rid="B46" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">
<italic>Celastrus orbiculatus </italic>
</td><td align="center" rowspan="1" colspan="1">1089.44</td><td align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">
<italic>Murraya euchrestifolia </italic>
</td><td align="center" rowspan="1" colspan="1">1066.97</td><td align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">
<italic>Melia azedarach </italic>
</td><td align="center" rowspan="1" colspan="1">980.47</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">40</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">
<italic>Datura metel </italic>
</td><td align="center" rowspan="1" colspan="1">894.36</td><td align="center" rowspan="1" colspan="1">[<xref rid="B48" ref-type="bibr">41</xref>, <xref rid="B49" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">
<italic>Ficus microcarpa </italic>
</td><td align="center" rowspan="1" colspan="1">837.65</td><td align="center" rowspan="1" colspan="1">[<xref rid="B50" ref-type="bibr">43</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">
<italic>Tripterygium wilfordii </italic>
</td><td align="center" rowspan="1" colspan="1">785.30</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">
<italic>Pachysandra terminalis </italic>
</td><td align="center" rowspan="1" colspan="1">740.38</td><td align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">
<italic>Calendula officinalis </italic>
</td><td align="center" rowspan="1" colspan="1">729.77</td><td align="center" rowspan="1" colspan="1">[<xref rid="B52" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">
<italic>Vitis vinifera </italic>
</td><td align="center" rowspan="1" colspan="1">719.77</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">46</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">
<italic>Melia toosendan </italic>
</td><td align="center" rowspan="1" colspan="1">711.49</td><td align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">
<italic>Mangifera indica </italic>
</td><td align="center" rowspan="1" colspan="1">677.08</td><td align="center" rowspan="1" colspan="1">[<xref rid="B54" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">
<italic>Piper nigrum </italic>
</td><td align="center" rowspan="1" colspan="1">667.41</td><td align="center" rowspan="1" colspan="1">[<xref rid="B55" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">
<italic>Solanum dulcamara </italic>
</td><td align="center" rowspan="1" colspan="1">667.12</td><td align="center" rowspan="1" colspan="1">[<xref rid="B56" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">
<italic>Garcinia hanburyi </italic>
</td><td align="center" rowspan="1" colspan="1">641.41</td><td align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">
<italic>Momordica charantia </italic>
</td><td align="center" rowspan="1" colspan="1">632.37</td><td align="center" rowspan="1" colspan="1">[<xref rid="B57" ref-type="bibr">50</xref>, <xref rid="B58" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">
<italic>Lantana camara </italic>
</td><td align="center" rowspan="1" colspan="1">625.64</td><td align="center" rowspan="1" colspan="1">[<xref rid="B59" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">
<italic>Ceriops tagal </italic>
</td><td align="center" rowspan="1" colspan="1">623.13</td><td align="center" rowspan="1" colspan="1">[<xref rid="B60" ref-type="bibr">53</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>